| |
| |
|
| Insider
Information: |
Saunders Brent L |
| Relationship: |
CEO and Chair, Director |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
6,432,115 |
|
|
Indirect Shares
|
2,802,951 |
|
|
| Direct
Value |
$91,671,978 |
|
|
|
Indirect Value
|
$39,241,314 |
|
|
| Total
Shares |
9,235,066 |
|
|
| Total
Value |
$130,913,292 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -20.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
Senior Vice President |
2009-11-03 |
0 |
2006-11-01 |
0 |
Premium* |
|
|
Allergan plc |
AGN |
Chairman, President an... |
2020-05-08 |
0 |
2014-07-01 |
0 |
Premium* |
|
|
Cisco Systems Inc |
CSCO |
Director |
2022-12-08 |
24,143 |
2017-03-13 |
0 |
Premium* |
|
|
Vesper Healthcare Acquisition Co... |
VSPRU |
Chairman, Director |
2023-08-16 |
5,827,453 |
2023-08-16 |
2,802,951 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-12-29 |
17,600 |
2021-12-29 |
0 |
Premium* |
|
|
Bausch & Lomb Corp |
BLCO |
CEO and Chair, Director |
2024-02-28 |
562,919 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2006-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2006-11-01 |
4 |
D |
$21.97 |
$254,588 |
D/D |
(11,588) |
13,412 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2006-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
28,412 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2006-12-01 |
4 |
D |
$21.93 |
$152,479 |
D/D |
(6,953) |
21,459 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2007-04-27 |
4 |
OE |
$15.27 |
$687,150 |
D/D |
45,000 |
66,459 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2007-04-27 |
4 |
S |
$31.62 |
$1,124,114 |
D/D |
(35,529) |
30,930 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2007-04-27 |
4 |
D |
$31.85 |
$301,651 |
D/D |
(9,471) |
21,459 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2008-04-25 |
4 |
D |
$18.64 |
$169,400 |
D/D |
(9,088) |
37,371 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2008-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
46,459 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2009-04-01 |
4 |
D |
$23.70 |
$274,636 |
D/D |
(11,588) |
50,783 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2009-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
62,371 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Senior Vice President |
• – – |
2009-11-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,783) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2014-07-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
135,507 |
135,507 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2014-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
96,865 |
96,865 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2014-08-15 |
4 |
D |
$216.10 |
$19,017 |
D/D |
(88) |
96,777 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2014-08-23 |
4 |
D |
$226.33 |
$24,443 |
D/D |
(108) |
96,669 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2015-05-15 |
4 |
D |
$296.60 |
$1,022,973 |
D/D |
(3,449) |
131,862 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2015-08-21 |
4 |
B |
$301.94 |
$301,940 |
D/D |
1,000 |
132,862 |
2.81 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2015-10-01 |
4 |
D |
$282.35 |
$2,142,189 |
D/D |
(7,587) |
125,275 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2016-06-30 |
4 |
D |
$231.09 |
$3,758,910 |
D/D |
(16,266) |
109,009 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2016-08-15 |
4 |
D |
$254.05 |
$27,437 |
D/D |
(108) |
108,901 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2016-10-01 |
4 |
D |
$230.31 |
$1,747,362 |
D/D |
(7,587) |
101,314 |
0 |
- |
|
| AGN |
Allergan plc |
CEO and President |
• • – |
2016-11-21 |
4 |
B |
$189.13 |
$992,941 |
D/D |
5,250 |
106,564 |
2.81 |
- |
|
| CSCO |
Cisco Systems Inc |
Director |
– • – |
2017-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,728 |
5,168 |
0 |
- |
|
| AGN |
Allergan plc |
Chairman, President and CEO |
• • – |
2017-03-29 |
4 |
B |
$242.21 |
$10,299 |
D/D |
43 |
131,135 |
2.81 |
- |
|
56 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
